Daylight Medical Adds New Model to SKY™ Mobile Device Disinfection Product Line

CLEVELAND, Jan. 21, 2015 /PRNewswire/ -- Daylight Medical, manufacturer and provider of innovative medical products, is pleased to announce the addition of a new model to its mobile hand-held device disinfection product line – the SKY 7Xi.

Using the same high intensity UVC technology as the SKY 6Xi model, SKY 7Xi disinfects in less than 25 seconds, and its vertical design expands siting capabilities for convenient placement on a desktop, mobile cart or wall mount.

From Electronic Medical Records (EMR) and patient surveys to on-call department phones and patient educational tools, mobile hand-held devices are prevalent in the healthcare environment. SKY 7Xi revolutionizes mobile hand-held device disinfection by standardizing the process, making it safer to use mobile devices anywhere, including critical care areas where patients are more susceptible to acquiring an HAI (Hospital-Acquired Infection).

The workflow-friendly design of the SKY 7Xi enables a mobile hand-held device to be quickly and easily processed. It swiftly travels through Daylight's patented articulating cartridge, allowing the high intensity (254 nanometer wavelength) ultraviolet light in the "C" spectrum (UVC) to come within 60 thousands of an inch of the mobile device surface. The result is timely and robust, immediately rendering pathogens on the device surface inactive. In just 25 seconds or less, the device is disinfected and ready for use.

"Our goal is to make mobile device disinfection standardized, easy, convenient and effective. SKY is accessible, fast and intuitive, and that combination helps drive user acceptance," said Rick Dayton, President of Daylight Medical. "Making the disinfection process less cumbersome encourages compliance. Frequent disinfection of mobile devices is the ideal scenario to significantly reduce cross-contamination." 

Achieving a 3-6 log reduction (99.9% to 99.9999%) in pathogens such as MRSA, VRE, MDR-gram negative, Norovirus and C.diff spores, SKY enables hand-held mobile devices to be used safely in the healthcare setting. This decrease in HAIs is vital as they can cause increased stays and readmissions for patients costing a hospital tens of thousands of dollars. SKY technology helps to create a disinfection standard, reducing the likelihood of cross-contamination. Hospitals that adopt SKY improve the safety of their patients and employees and help to significantly combat the transmission of harmful HAIs. Daylight Medical's SKY 6Xi model was introduced in April 2014.

All results based on independent testing. C. difficile was tested directly and, for safety and equivalence, challenge organisms of greater irradiation resistance replaced other pathogens noted. Tests conducted with Pseudomonas aeruginosa, Staphylococcus aureus, and Bacillus atrophaeus.

Media Contact:   
Gayle Harper 
800-459-8500 x 226 
Email

Photo - http://photos.prnewswire.com/prnh/20150120/170311

SOURCE Daylight Medical

Related Links

http://www.daylightmedical.com